{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T21:15:28Z","timestamp":1769980528822,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,6,14]],"date-time":"2010-06-14T00:00:00Z","timestamp":1276473600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Signal transduction processes mediated by phosphatidyl inositol phosphates affect a broad range of cellular processes such as cell cycle progression, migration and cell survival. The protein kinase AKT is one of the major effectors in this signaling network. Chronic AKT activation contributes to oncogenic transformation and tumor development. Therefore, analogs of phosphatidyl inositol phosphates (PIAs) were designed as new small drugs to block AKT activity for cancer treatment. Here we characterize the biological effects of the PIAs SH-5 and SH-6 in colorectal cancer cell lines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Serum-starved or serum-supplemented human colorectal cancer cell lines SW480, HT29 and HCT116 were exposed to SH-5 and SH-6. AKT activation was determined by western blotting. Cell viability was assessed using a colorimetric XTT-based assay, apoptosis and cell cycle changes were monitored by FACS analysis. The dynamics of cell morphology alterations was evaluated by confocal and time-lapse microscopy. Transcriptional changes due to inhibitor treatment were analyzed using Affymetrix HG-U133A microarrays and RT-PCR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>While the PIAs clearly reduce AKT phosphorylation in serum starved cells, we did not observe a significant reduction under serum supplemented conditions, giving us the opportunity to analyze AKT independent effects of these compounds. Both inhibitors induce broadly the same morphological alterations, in particular changes in cell shape and formation of intracellular vesicles. Moreover, we observed the induction of binucleated cells specifically in the SW480 cell line. Gene expression analysis revealed transcriptional alterations, which are mostly cell line specific. In accordance to the phenotype we found a gene group associated with mitosis and spindle organization down regulated in SW480 cells, but not in the other cell lines. A bioinformatics analysis using the Connectivity Map linked the gene expression pattern of the inhibitor treated SW480 cells to PKC signaling. Using confocal laser scanning microscopy and time lapse recording we identified a specific defect in the last step of the cytokinesis as responsible for the binucleation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The PIAs SH-5 and SH-6 impinge on additional cellular targets apart from AKT in colorectal cancer cells. The effects are mostly cell line specific and have an influence at the outcome of the treatment. In view of potential clinical trials it will be necessary to take these diverse effects into consideration to optimize patient treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-10-287","type":"journal-article","created":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T06:15:54Z","timestamp":1276582554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Characterization of AKT independent effects of the synthetic AKT inhibitors SH-5 and SH-6 using an integrated approach combining transcriptomic profiling and signaling pathway perturbations"],"prefix":"10.1186","volume":"10","author":[{"given":"Till","family":"Krech","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarethe","family":"Thiede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Hilgenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhold","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"J\u00fcrchott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,14]]},"reference":[{"key":"2086_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00232-003-2027-7","volume":"194","author":"RL Doughman","year":"2003","unstructured":"Doughman RL, Firestone AJ, Anderson RA: Phosphatidylinositol phosphate kinases put PI4,5P(2) in its place. J Membr Biol. 2003, 194: 77-89. 10.1007\/s00232-003-2027-7.","journal-title":"J Membr Biol"},{"key":"2086_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1042\/BC20050081","volume":"98","author":"MR Logan","year":"2006","unstructured":"Logan MR, Mandato CA: Regulation of the actin cytoskeleton by PIP2 in cytokinesis. Biol Cell. 2006, 98: 377-388. 10.1042\/BC20050081.","journal-title":"Biol Cell"},{"key":"2086_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1083\/jcb.200603156","volume":"174","author":"C Janetopoulos","year":"2006","unstructured":"Janetopoulos C, Devreotes P: Phosphoinositide signaling plays a key role in cytokinesis. J Cell Biol. 2006, 174: 485-490. 10.1083\/jcb.200603156.","journal-title":"J Cell Biol"},{"key":"2086_CR4","doi-asserted-by":"publisher","first-page":"9027","DOI":"10.1074\/jbc.M106755200","volume":"277","author":"MP Scheid","year":"2002","unstructured":"Scheid MP, Huber M, Damen JE, Hughes M, Kang V, Neilsen P, Prestwich GD, Krystal G, Duronio V: Phosphatidylinositol (3,4,5)P3 is essential but not sufficient for protein kinase B (PKB) activation; phosphatidylinositol (3,4)P2 is required for PKB phosphorylation at Ser-473: studies using cells from SH2-containing inositol-5-phosphatase knockout mice. J Biol Chem. 2002, 277: 9027-9035. 10.1074\/jbc.M106755200.","journal-title":"J Biol Chem"},{"key":"2086_CR5","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1002\/cncr.10591","volume":"94","author":"N Itoh","year":"2002","unstructured":"Itoh N, Semba S, Ito M, Takeda H, Kawata S, Yamakawa M: Phosphorylation of Akt\/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma. Cancer. 2002, 94: 3127-3134. 10.1002\/cncr.10591.","journal-title":"Cancer"},{"key":"2086_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/carcin\/23.1.201","volume":"23","author":"HK Roy","year":"2002","unstructured":"Roy HK, Olusola BF, Clemens DL, Karolski WJ, Ratashak A, Lynch HT, Smyrk TC: AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. Carcinogenesis. 2002, 23: 201-205. 10.1093\/carcin\/23.1.201.","journal-title":"Carcinogenesis"},{"key":"2086_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"I Vivanco","year":"2002","unstructured":"Vivanco I, Sawyers CL: The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2002, 2: 489-501. 10.1038\/nrc839.","journal-title":"Nat Rev Cancer"},{"key":"2086_CR8","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/nrd1902","volume":"4","author":"BT Hennessy","year":"2005","unstructured":"Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB: Exploiting the PI3K\/AKT pathway for cancer drug discovery. Nat Rev Drug Discov. 2005, 4: 988-1004. 10.1038\/nrd1902.","journal-title":"Nat Rev Drug Discov"},{"key":"2086_CR9","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1021\/ja0285159","volume":"125","author":"AP Kozikowski","year":"2003","unstructured":"Kozikowski AP, Sun H, Brognard J, Dennis PA: Novel PI analogues selectively block activation of the pro-survival serine\/threonine kinase Akt. J Am Chem Soc. 2003, 125: 1144-1145. 10.1021\/ja0285159.","journal-title":"J Am Chem Soc"},{"key":"2086_CR10","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1158\/0008-5472.CAN-03-1530","volume":"64","author":"SS Castillo","year":"2004","unstructured":"Castillo SS, Brognard J, Petukhov PA, Zhang C, Tsurutani J, Granville CA, Li M, Jung M, West KA, Gills JG, Kozikowski AP, Dennis PA: Preferential inhibition of Akt and killing of Akt-dependent cancer cells by rationally designed phosphatidylinositol ether lipid analogues. Cancer Res. 2004, 64: 2782-2792. 10.1158\/0008-5472.CAN-03-1530.","journal-title":"Cancer Res"},{"key":"2086_CR11","doi-asserted-by":"publisher","first-page":"27020","DOI":"10.1074\/jbc.M701108200","volume":"282","author":"JJ Gills","year":"2007","unstructured":"Gills JJ, Castillo SS, Zhang C, Petukhov PA, Memmott RM, Hollingshead M, Warfel N, Han J, Kozikowski AP, Dennis PA: Phosphatidylinositol ether lipid analogues that inhibit AKT also independently activate the stress kinase, p38alpha, through MKK3\/6-independent and -dependent mechanisms. J Biol Chem. 2007, 282: 27020-27029. 10.1074\/jbc.M701108200.","journal-title":"J Biol Chem"},{"key":"2086_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1158\/1535-7163.MCT-05-0484","volume":"5","author":"JJ Gills","year":"2006","unstructured":"Gills JJ, Holbeck S, Hollingshead M, Hewitt SM, Kozikowski AP, Dennis PA: Spectrum of activity and molecular correlates of response to phosphatidylinositol ether lipid analogues, novel lipid-based inhibitors of Akt. Mol Cancer Ther. 2006, 5: 713-722. 10.1158\/1535-7163.MCT-05-0484.","journal-title":"Mol Cancer Ther"},{"key":"2086_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/(SICI)1097-0142(19980701)83:1<41::AID-CNCR6>3.0.CO;2-H","volume":"83","author":"WA Phillips","year":"1998","unstructured":"Phillips WA, St Clair F, Munday AD, Thomas RJ, Mitchell CA: Increased levels of phosphatidylinositol 3-kinase activity in colorectal tumors. Cancer. 1998, 83: 41-47. 10.1002\/(SICI)1097-0142(19980701)83:1<41::AID-CNCR6>3.0.CO;2-H.","journal-title":"Cancer"},{"key":"2086_CR14","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1126\/science.1096502","volume":"304","author":"Y Samuels","year":"2004","unstructured":"Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, Willson JKV, Markowitz S, Kinzler KW, Vogelstein B, Velculescu VE: High frequency of mutations of the PIK3CA gene in human cancers. Science. 2004, 304: 554-10.1126\/science.1096502.","journal-title":"Science"},{"key":"2086_CR15","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.1038\/sj.onc.1204611","volume":"20","author":"J Gayet","year":"2001","unstructured":"Gayet J, Zhou XP, Duval A, Rolland S, Hoang JM, Cottu P, Hamelin R: Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. Oncogene. 2001, 20: 5025-5032. 10.1038\/sj.onc.1204611.","journal-title":"Oncogene"},{"key":"2086_CR16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/1471-2105-6-232","volume":"6","author":"R Shamir","year":"2005","unstructured":"Shamir R, Maron-Katz A, Tanay A, Linhart C, Steinfeld I, Sharan R, Shiloh Y, Elkon R: EXPANDER--an integrative program suite for microarray data analysis. BMC Bioinformatics. 2005, 6: 232-10.1186\/1471-2105-6-232.","journal-title":"BMC Bioinformatics"},{"key":"2086_CR17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/jb\/mvj209","volume":"140","author":"Y Naito","year":"2006","unstructured":"Naito Y, Okada M, Yagisawa H: Phospholipase C isoforms are localized at the cleavage furrow during cytokinesis. J Biochem. 2006, 140: 785-791. 10.1093\/jb\/mvj209.","journal-title":"J Biochem"},{"key":"2086_CR18","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet J, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR: The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006, 313: 1929-1935. 10.1126\/science.1132939.","journal-title":"Science"},{"key":"2086_CR19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jcp.20956","volume":"211","author":"JY Han","year":"2007","unstructured":"Han JY, Heo JS, Lee YJ, Lee JH, Taub M, Han HJ: Dopamine stimulates 45Ca2+ uptake through cAMP, PLC\/PKC, and MAPKs in renal proximal tubule cells. J Cell Physiol. 2007, 211: 486-494. 10.1002\/jcp.20956.","journal-title":"J Cell Physiol"},{"key":"2086_CR20","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1083\/jcb.200302129","volume":"162","author":"T Raemaekers","year":"2003","unstructured":"Raemaekers T, Ribbeck K, Beaudouin J, Annaert W, Van Camp M, Stockmans I, Smets N, Bouillon R, Ellenberg J, Carmeliet G: NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization. J Cell Biol. 2003, 162: 1017-1029. 10.1083\/jcb.200302129.","journal-title":"J Cell Biol"},{"key":"2086_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.cub.2006.11.050","volume":"17","author":"K Ribbeck","year":"2007","unstructured":"Ribbeck K, Raemaekers T, Carmeliet G, Mattaj IW: A role for NuSAP in linking microtubules to mitotic chromosomes. Curr Biol. 2007, 17: 230-236. 10.1016\/j.cub.2006.11.050.","journal-title":"Curr Biol"},{"key":"2086_CR22","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.4161\/cc.6.13.4356","volume":"6","author":"M Paramasivam","year":"2007","unstructured":"Paramasivam M, Chang YJ, LoTurco JJ: ASPM and citron kinase co-localize to the midbody ring during cytokinesis. Cell Cycle. 2007, 6: 1605-1612.","journal-title":"Cell Cycle"},{"key":"2086_CR23","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1242\/jcs.02614","volume":"118","author":"SV Holt","year":"2005","unstructured":"Holt SV, Vergnolle MAS, Hussein D, Wozniak MJ, Allan VJ, Taylor SS: Silencing Cenp-F weakens centromeric cohesion, prevents chromosome alignment and activates the spindle checkpoint. J Cell Sci. 2005, 118: 4889-4900. 10.1242\/jcs.02614.","journal-title":"J Cell Sci"},{"key":"2086_CR24","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1097-2765(00)80302-0","volume":"2","author":"W Jiang","year":"1998","unstructured":"Jiang W, Jimenez G, Wells NJ, Hope TJ, Wahl GM, Hunter T, Fukunaga R: PRC1: a human mitotic spindle-associated CDK substrate protein required for cytokinesis. Mol Cell. 1998, 2: 877-885. 10.1016\/S1097-2765(00)80302-0.","journal-title":"Mol Cell"},{"key":"2086_CR25","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1091\/mbc.E04-04-0346","volume":"16","author":"C Mollinari","year":"2005","unstructured":"Mollinari C, Kleman J, Saoudi Y, Jablonski SA, Perard J, Yen TJ, Margolis RL: Ablation of PRC1 by small interfering RNA demonstrates that cytokinetic abscission requires a central spindle bundle in mammalian cells, whereas completion of furrowing does not. Mol Biol Cell. 2005, 16: 1043-1055. 10.1091\/mbc.E04-04-0346.","journal-title":"Mol Biol Cell"},{"key":"2086_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1006\/excr.1999.4701","volume":"253","author":"B Vanhaesebroeck","year":"1999","unstructured":"Vanhaesebroeck B, Waterfield MD: Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res. 1999, 253: 239-254. 10.1006\/excr.1999.4701.","journal-title":"Exp Cell Res"},{"key":"2086_CR27","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0092-8674(02)01197-2","volume":"111","author":"CW Taylor","year":"2002","unstructured":"Taylor CW: Controlling calcium entry. Cell. 2002, 111: 767-769. 10.1016\/S0092-8674(02)01197-2.","journal-title":"Cell"},{"key":"2086_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bbamem.2005.06.008","volume":"1714","author":"B Olas","year":"2005","unstructured":"Olas B, Wachowicz B, Holmsen H, Fukami MH: Resveratrol inhibits polyphosphoinositide metabolism in activated platelets. Biochim Biophys Acta. 2005, 1714: 125-133. 10.1016\/j.bbamem.2005.06.008.","journal-title":"Biochim Biophys Acta"},{"key":"2086_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.bbrc.2005.12.025","volume":"340","author":"DB Whyte","year":"2006","unstructured":"Whyte DB, Holbeck SL: Correlation of PIK3Ca mutations with gene expression and drug sensitivity in NCI-60 cell lines. Biochem Biophys Res Commun. 2006, 340: 469-475. 10.1016\/j.bbrc.2005.12.025.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-287.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-10-287\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-287.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:13:31Z","timestamp":1630613611000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-10-287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,14]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["2086"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-10-287","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,14]]},"assertion":[{"value":"14 January 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"287"}}